John L. Knopf, CEO and President at ACCELERON PHARMA INC (XLRN), sold 100,000 shares at $34.18 ($3.4M) on 2016-07-01, disclosed to the SEC on 2016-07-06.
Open-market sale of $3.4M XLRN by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.18 | 7,396 | $253K | 7.5% |
| 2 | $34.92 | 20,626 | $720K | 21.3% |
| 3 | $33.18 | 28,111 | $933K | 27.5% |
| 4 | $34.22 | 2,390 | $82K | 2.4% |
| 5 | $33.58 | 31,040 | $1.0M | 30.8% |
| 6 | $34.26 | 10,437 |
| $358K |
| 10.6% |
| Total | $33.87 avg | 100,000 | $3.4M | 100% |
| Filing → |
| XLRN | SELL | 2015-10-09 | $463K | — | Filing → |
| XLRN | SELL | 2015-09-10 | $574K | — | Filing → |
| XLRN | SELL | 2015-08-12 | $542K | — | Filing → |